By 2030, surveyed executives anticipate AI spend to shift from efficiency to innovation AI productivity gains projected to increase by 42%, fueling reinvestment for growth 67% of respondents expect AI to eliminate resource and skills constraints ARMONK, N.Y., Jan. 19, 2026 /PRNewswire/ — New research from the IBM (NYSE: IBM) Institute for Business Value reveals… Continue reading IBM Study: AI Poised to Drive Smarter Business Growth Through 2030
Category: Newswire
W. LUNABELLA Elevates K-Beauty: Unveils Premier ‘Total Beauty Solution Hub’ in Paris’ Iconic Le Marais
PARIS, Jan. 19, 2026 /PRNewswire/ — LUNABELLA, a visionary force in K-Beauty, today announces the monumental grand opening of its flagship “W. LUNABELLA” in Paris’ historic Le Marais district this March, perfectly timed with Paris Fashion Week. More than a conventional boutique, this sprawling sanctuary is meticulously crafted as a “Total Beauty Solution Hub” –… Continue reading W. LUNABELLA Elevates K-Beauty: Unveils Premier ‘Total Beauty Solution Hub’ in Paris’ Iconic Le Marais
/C O R R E C T I O N — Ampace/
In the news release, Ampace and DG Matrix Announce Strategic Partnership to Deliver First UL-Certified Grid-Active BESS Integrated with Multi-Port Solid-State Transformer Architecture for AI Data Centers, issued 17-Dec-2025 by Ampace over PR Newswire, we are advised by the company that the 6th paragraph, first sentence, should read “Brad Li, President of Ampace Americas Region,… Continue reading /C O R R E C T I O N — Ampace/
X-Sense eröffnet deutsche Niederlassung zur Stärkung des Brandschutzes in Europa
LANGEN, Deutschland, 19. Januar 2026 /PRNewswire/ — X-Sense, ein weltweit führendes Unternehmen im Bereich Smart-Home- und Brandschutztechnologie, hat seine deutsche Niederlassung, X-Sense DACH GmbH, in der Monzastraße 2B in Langen, Hessen, eröffnet. Strategisch gelegen in der Nähe des Frankfurter Flughafens und Hauptbahnhofs bietet das neue Büro eine verkehrsgünstige Lage für Kunden, Partner und Serviceteams in… Continue reading X-Sense eröffnet deutsche Niederlassung zur Stärkung des Brandschutzes in Europa
Chassis Supply Chain’s “iPhone Moment”: China’s Tier 1 Shift as LeeKr Emerges
SHANGHAI, Jan. 19, 2026 /PRNewswire/ — Over the past decade, China’s electric vehicle (EV) industry has evolved from a niche experiment into a leading force in the global automotive landscape. In the first ten months of 2025, China exported over 2 million EVs, nearly double the year-earlier figure. From European city streets to Southeast Asian highways… Continue reading Chassis Supply Chain’s “iPhone Moment”: China’s Tier 1 Shift as LeeKr Emerges
Monster Energy’s Freeski and Snowboard Athletes Claim Victories and Podium Finishes in Key Competitions at the 2026 LAAX OPEN in Switzerland
Women’s Snowboard Halfpipe: 17-Year-Old Gaon Choi from South Korea Takes 1st Place Women’s Snowboard Slopestyle: 21-Year-Old Kokomo Murase from Japan Claims Win, 16-Year-Old Lily Dhawornvej from Colorado Finishes in 2nd Place Men’s Freeski Slopestyle: 25-Year-Old Birk Ruud Claims 1st Place, Evan McEachran 3rd Place Men’s Snowboard Halfpipe: 19-Year-Old Campbell Melville Ives from New Zealand Takes 2nd Place LAAX, Switzerland, Jan.… Continue reading Monster Energy’s Freeski and Snowboard Athletes Claim Victories and Podium Finishes in Key Competitions at the 2026 LAAX OPEN in Switzerland
D3 Bio Receives U.S. FDA Clearance for Two IND Applications, Enabling Phase 1 Trial of D3S‑003 and Phase 2 Combination Study of Elisrasib (D3S‑001) with D3S‑002
SHANGHAI, Jan. 18, 2026 /PRNewswire/ — D3 Bio, a global clinical‑stage biotechnology company focused on developing transformative oncology therapeutics, today announced that the U.S. Food and Drug Administration (FDA) has cleared two Investigational New Drug (IND) applications: D3S‑003 — a KRAS G12D inhibitor — enabling the start of a Phase 1 first‑in‑human clinical trial. A Phase… Continue reading D3 Bio Receives U.S. FDA Clearance for Two IND Applications, Enabling Phase 1 Trial of D3S‑003 and Phase 2 Combination Study of Elisrasib (D3S‑001) with D3S‑002
JAPAN SUI COLLECTION in Kyoto: Die Essenz japanischer Schönheit und Tradition in die Welt tragen – Bericht über die Veranstaltung im Gästehaus der Präfektur Kyoto
– Nach dem Erfolg in Kyoto kommt die JAPAN SUI COLLECTION im März 2026 nach Europa – TOKIO, 19. Januar 2026 /PRNewswire/ — Das Kabinettsamt der japanischen Regierung veranstaltete vom 14. bis 15. November 2025 in Kyoto die Veranstaltung „JAPAN SUI COLLECTION in KYOTO”. Japan ist die Heimat unzähliger traditioneller Handwerkskünste, regionaler Spezialitäten und Lebensmittel,… Continue reading JAPAN SUI COLLECTION in Kyoto: Die Essenz japanischer Schönheit und Tradition in die Welt tragen – Bericht über die Veranstaltung im Gästehaus der Präfektur Kyoto
AbelZeta Announces Remaining China Rights to GPC3 Armored CAR-T Therapy to be Acquired by AstraZeneca
ROCKVILLE, Md. and SHANGHAI, Jan. 18, 2026 /PRNewswire/ — AbelZeta Pharma, Inc. (“AbelZeta”), a global clinical-stage biopharmaceutical company focused on the discovery and development of innovative and proprietary cell-based therapeutic products, announced that AstraZeneca has agreed to acquire AbelZeta’s 50% share of the China development and commercialization rights to C-CAR031, such that AstraZeneca acquires the… Continue reading AbelZeta Announces Remaining China Rights to GPC3 Armored CAR-T Therapy to be Acquired by AstraZeneca
Harbour BioMed Acquires Common Stock in Spruce Biosciences, Deepening Strategic Collaboration
CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, Jan. 18, 2026 /PRNewswire/ — Harbour BioMed (HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology and oncology, today announced that through its wholly-owned subsidiary, it has exercised its warrant to acquire the common stock in Spruce Biosciences, Inc. (Nasdaq: SPRB) (“Spruce”). Following… Continue reading Harbour BioMed Acquires Common Stock in Spruce Biosciences, Deepening Strategic Collaboration